Notícias · Recifes

Urgent call for better access to personalized cancer care

A University of Queensland study has found that patient access to one of the most exciting frontiers in cancer treatment is being stalled because health systems struggle to accurately assess its cost-effectiveness. The study, "Assessing Value for Money in Theranostic Nuclear Medi

Admin Recifes 15/07/2026 2

Stopping skin cancer before it starts could cut its health care costs

A new study has revealed the hundreds of thousands of skin cancer appointments and medical procedures Queenslanders are attending and undergoing each year, prompting experts to call for further investment in prevention campaigns to protect public health and ease pressure on the h

Admin Recifes 15/07/2026 2

Lived experience is often dismissed—but we should recognize it as a form of expertise

Institutions increasingly invite people to contribute their lived experience. Government agencies appoint patients to advisory panels and call on communities for their views on policy. Health New Zealand employs peer support workers, and universities seek lived experience in rese

Admin Recifes 15/07/2026 1

DNA damage can trigger neurons to self-destruct

Over the past decade, researchers at WashU Medicine have established that a molecule called SARM1 is a central trigger in the loss of axons, the vital wiring of the nervous system. Axon loss is characteristic of many neurodegenerative diseases, such as amyotrophic lateral scleros

Admin Recifes 15/07/2026 2

Should lowest-risk prostate 'cancer' still be called cancer? How changing the name could s

A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good. A new UCLA-led study found removing the cancer label could dramatically reduce overtreatment and encourage more men to get screened, potentially leadi

Admin Recifes 15/07/2026 1

Discovery could help prevent cancer drug resistance before it starts

Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of California, Davis, shows how cancers adapt to evade a class of anti-tumor drugs called BET inhibitors and offers hope for more effective therapies.

Admin Recifes 15/07/2026 2

Hearing loss in diabetes patients a 'hidden epidemic'

Researchers are calling for hearing tests to become a standard part of diabetes care and for hearing loss to be recognized as a significant complication of the condition. Dr. Mehwish Nisar from UQ's School of Public Health said most people were unaware there was even a connection

Admin Recifes 15/07/2026 2

7 things to know about Medicare's new GLP-1 coverage

For decades, it's been against the law for Medicare to pay for weight-loss medication. But that changed on July 1, with the launch of a new program called Bridge. It gives some people over 65, or who have Medicare for other reasons, access to some weight management medications if

Admin Recifes 15/07/2026 2

Researchers call for increased screening for parasitic disease linked to HIV and cervical

New research from Liverpool School of Tropical Medicine (LSTM) has highlighted the need to test millions of women and girls for female genital schistosomiasis (FGS), a neglected disease that can increase the risk of chronic illness, HIV and cervical cancer.

Admin Recifes 15/07/2026 2

Nursing leaders call on profession to amplify its impact ahead of U.S. semiquincentennial

As the United States prepares to mark its 250th anniversary, Penn Nursing leaders are issuing a joint call to action for the nursing profession. In separate commentaries published in the July 2026 issue of the American Journal of Nursing (AJN), Antonia M. Villarruel, PhD, RN, FAA

Admin Recifes 15/07/2026 1

Forcing cancer cells to die can alert the immune system to enhance anti-tumor attack

Unlike accidental cell death, some cells can actively decide to die through a controlled process. This is called programmed cell death and can occur in different forms, including apoptosis and necroptosis. Cells use this process when they are damaged, stressed, becoming cancerous

Admin Recifes 15/07/2026 1

Platinum TALEN enables mass production of engineered cancer-fighting T cells

Hiroshima University researchers have demonstrated a proof of concept for the mass production of genome-edited T cells that can be used to treat malignant tumors, using a genetic engineering technique called Platinum TALEN.

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes